SCIENTIFIC RESEARCH
In response to Dr. Michael Greger’s significantly misleading video on Klamath Lake blue-green algae, we present decades of evidence-based scientific research, recent genetic sequencing, and collaboration with federal and international regulatory agencies that disprove each of Dr. Greger’s outrageous claims.
Dr. Greger’s claims about AFA toxicity are not only inaccurate but also irresponsibly ignore the extensive safety clearances from the FDA and other global health agencies around the world.
With over 30 years of experience as primary harvesters and aquatic farmers of this unique blue-green algae, we bring forward independent studies that show conclusively the safety and truth of this particular variety of AFA. We counter each falsification that Greger makes, point-by-point, showing why Klamath Lake AFA is a safe, unique, and nutrient-rich supplement that has transformed lives.
If you care about accurate nutrition information, this video is a must-watch.
SCIENTIFIC BREAKTHROUGH:
DNA Sequencing Confirms Non-Toxic Subspecies of Aphanizomenon flos-aquae (AFA) from Upper Klamath Lake
KLAMATH FALLS, OR, UNITED STATES, October 25, 2024
Recent advancements in genomic research have led to a pivotal discovery in the study of Aphanizomenon flos-aquae (AFA), a cyanobacterium often regarded as a homogeneous species. The newly completed DNA-based study, conducted by SeqCoast Genomics in Portsmouth, NH, has confirmed that AFA harvested from Upper Klamath Lake is genetically distinct from other AFA strains, confirming years of safety data about this
dietary supplement.
New Genome Sequencing Proves Species Differentiation
Advanced genomic analysis confirms that AFA from Upper Klamath Lake is part of a genetically unique subspecies that is different from the few AFA strains that been reported to be toxin producers. Genome sequencing now recognizes at least 18 distinct varieties of AFA, each possessing unique characteristics that distinguish them from one another. This finding brings clarity to years of misinterpretation of the scientific literature that oftentimes treated AFA as a homogeneous species.
Non-Toxic Strain from Upper Klamath Lake
Most significant in this discovery is the confirmation that AFA from Upper Klamath Lake, —identified as AFA MDT14a—is incapable of producing harmful toxins such as Cylindrospermopsin, microcystin, saxitoxin or anatoxin-a. This finding directly challenges the general belief that all AFA species pose risks of toxicity, thus confirming the safety of consumable products derived from this particular strain. These results align with the broader understanding, after decades of rigorous testing, that AFA from Klamath Lake is non-toxic.
Health Benefits of AFA
The health benefits of AFA consumption have been documented for more than two decades. AFA supports immune functions, more specifically the activation and migration of NK cells, it contains phycocyanin that has been shown to have strong anti-inflammatory properties, and it contains phenylethylamine documented to support mental clarity and mood elevation. AFA is also the first natural plant-based product documented to support stem cell mobilization and function in the body, explaining the broad spectrum of health benefits reported by consumers.
Updating AFA Studies Based on Genomic Differentiation
The recent genomic evidence distinguishing Aphanizomenon flos-aquae (AFA) strains compels a re-examination of many wrongful interpretations and confirms the safety of Klamath Lake AFA as a dietary supplement. This new differentiation between toxic and non-toxic strains highlights the need to be extremely cautious when reading previous interpretations of the scientific literature. In line with scientific progress, previous literature must be reassessed to reflect this specificity, especially regarding nutritional and toxicological properties. Although AFA has been registered worldwide as a dietary supplement based on years of testing establishing its safety, this new finding will be a new tool for researchers, regulatory agencies, and public health officials in confirming the safety of AFA.
References
Genome. (n.d.-b). NCBI.
https://www.ncbi.nlm.nih.gov/datasets/genome/?taxon=1176
Taxonomy. (n.d.). Taxonomy browser (Aphanizomenon flos-aquae).
https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&id=1176&lvl=3&keep=1&srchmode=1&unlock
Driscoll, C. B., et al. (2018). “A closely-related clade of globally distributed bloom-forming cyanobacteria within the Nostocales.” Harmful Algae, 77, 93–107.
https://doi.org/10.1016/j.hal.2018.05.009
Dreher, T. W., et al. (2022). “7-epi-cylindrospermopsin and microcystin producers among diverse Anabaena/Dolichospermum/Aphanizomenon CyanoHABs in Oregon, USA.” Harmful Algae,
116, 102241.
https://doi.org/10.1016/j.hal.2022.102241
Merino, J. J., et al. (2020). “The Bluegreen Algae (AFA) Consumption over 48 h Increases the Total Number of Peripheral CD34+ Cells in Healthy Patients.” Journal of Personalized
Medicine, 10(2), 49.
https://doi.org/10.3390/jpm10020049
https://www.fda.gov/food/chemical-contaminants-pesticides/natural-toxins-food
